Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SANDOZ AMOXI-CLAV TABLET 125 MG — DIN 02482584

CLAVULANIC ACID (CLAVULANATE POTASSIUM) : 125 MG AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 875 MG · SANDOZ CANADA INCORPORATED · TABLET · wholesale supply in Canada

Health Canada status: MARKETED

What is SANDOZ AMOXI-CLAV TABLET?

SANDOZ AMOXI-CLAV TABLET 125 MG contains CLAVULANIC ACID (CLAVULANATE POTASSIUM) : 125 MG AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 875 MG. It is listed in the Health Canada Drug Product Database under DIN 02482584, held by SANDOZ CANADA INCORPORATED, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 01-Mar-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is SANDOZ AMOXI-CLAV TABLET used for?

Sandoz Amoxi-Clav Tablet (Amoxicillin and Clavulanate potassium tablets) is indicated for the treatment of Sinusitis, Otitis Media, Lower Respiratory Tract Infections, Skin and Soft Tissue Infections, and Urinary Tract Infections when caused by susceptible strains of designated bacteria.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

How much does Amoxicillin And Beta-Lactamase Inhibitor cost around the world?

Amoxicillin And Beta-Lactamase Inhibitor is listed on 15 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
Saudi Arabiapublic153166SAR███.██
Australiaex-manufacturer34132AUD███.██
South Africasingle exit price96122ZAR███.██
United Statesacquisition1098USD███.██
Bahrainretail (max)3693BHD███.██
Czechiamax producer price (ex-factory)1541CZK███.██
Romaniamax producer price2541RON███.██
SwedenAIP (pharmacy purchase price)1438SEK███.██
AustriaKVP (Kassenverkaufspreis)1832EUR███.██
United Kingdomhospital1515GBP███.██
Luxembourgreimbursement99EUR███.██
Icelandmax wholesale35ISK███.██
Greeceproducer price (ex-factory)44EUR███.██
Hungaryproducer price (ex-factory)33HUF███.██
Lebanonpublic price (USD, Decision 119/1)11USD███.██

800 pack listings across 436 brand entries and 14 price bases, refreshed 08 Sep 2026. Ranges span every Amoxicillin And Beta-Lactamase Inhibitor pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Amoxicillin And Beta-Lactamase Inhibitor in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

14 holders have a Canadian DIN containing Amoxicillin And Beta-Lactamase Inhibitor, across 59 DINs, of which 28 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
JAMP PHARMA CORPORATION65JAMP AMOXI CLAV, JAMP AMOXI CLAV SUSPENSIONSourceable in Canada
SANDOZ CANADA INCORPORATED55AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION, SANDOZ AMOXI-CLAV TABLETSourceable in Canada
GLAXOSMITHKLINE INC74CLAVULIN 125 F ORAL SUS, CLAVULIN 200, CLAVULIN 250 F ORAL SUS, CLAVULIN 250 TAB, CLAVULIN 400, +2 moreSourceable in Canada
APOTEX INC93APO-AMOXI CLAV, APO-AMOXI CLAV 125MG/31.25MG PER 5ML, APO-AMOXI CLAV 250MG/62.5MG PER 5ML, APO-AMOXICILLIN-CLAVULANATESourceable in Canada
AURO PHARMA INC33AURO-AMOXICLAVSourceable in Canada
ANGITA PHARMA INC.62AG-AMOXI CLAV, AG-AMOXI CLAV SUSPENSIONSourceable in Canada
PRO DOC LIMITEE52AMOXI-CLAV, PRO-AMOXI CLAVSourceable in Canada
MANTRA PHARMA INC22M-AMOXI CLAVSourceable in Canada
SANIS HEALTH INC22AMOXICILLIN/CLAVSourceable in Canada
TEVA CANADA LIMITED40RATIO-ACLAVULANATE, RATIO-ACLAVULANATE 125 F, RATIO-ACLAVULANATE 250 FNo marketed DIN
NOVOPHARM LIMITED30NOVO-CLAVAMOXIN 125, NOVO-CLAVAMOXIN 250, NOVO-CLAVAMOXIN 875No marketed DIN
PHARMASCIENCE INC30PMS-AMCLAV-200, PMS-AMCLAV-400, PMS-AMCLAV-875No marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label125 MG
Dosage formTABLET
RouteORAL
Pack configuration (monograph)Bottles of 100 tablets
Storagenull

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substanceAmoxicillin And Beta-Lactamase Inhibitor
ATC codeJ01CR02
AHFS class08:12.16.08
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02482584
DIN (unpadded, as printed on some documents)2482584
Brand nameSANDOZ AMOXI-CLAV TABLET
Generic / active ingredientCLAVULANIC ACID (CLAVULANATE POTASSIUM) : 125 MG AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 875 MG
Market authorization holderSANDOZ CANADA INCORPORATED
Health Canada schedulePrescription
ATC codeJ01CR02
ATC anatomical main groupJ — Anti-infectives for systemic use
ATC therapeutic subgroupJ01CR
Current statusMARKETED
Status date01-Mar-2019
Original market date2019-03-01 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

Is Amoxicillin And Beta-Lactamase Inhibitor in shortage in Canada?

A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for SANDOZ AMOXI-CLAV TABLET

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

28 of 59 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
AG-AMOXI CLAV500 MGTABLETANGITA PHARMA INC.MARKETED02510634
AG-AMOXI CLAV875 MGTABLETANGITA PHARMA INC.MARKETED02510642
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION100 MGPOWDER FOR SOLUTIONSANDOZ CANADA INCORPORATEDMARKETED02495910
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION2000 MGPOWDER FOR SOLUTIONSANDOZ CANADA INCORPORATEDMARKETED02495937
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION1000 MGPOWDER FOR SOLUTIONSANDOZ CANADA INCORPORATEDMARKETED02495929
AMOXICILLIN/CLAV500 MGTABLETSANIS HEALTH INCMARKETED02536021
AMOXICILLIN/CLAV875 MGTABLETSANIS HEALTH INCMARKETED02536048
APO-AMOXI CLAV125 MGTABLETAPOTEX INCMARKETED02243350
APO-AMOXI CLAV875 MGTABLETAPOTEX INCMARKETED02245623
APO-AMOXI CLAV500 MGTABLETAPOTEX INCMARKETED02243351

2 · Same class — other molecules in ATC J01CR

MoleculeCanadian brandsDINsMarketedSourceable
Amoxicillin And Beta-Lactamase InhibitorAG-AMOXI CLAV · AG-AMOXI CLAV SUSPENSION · AMOXI-CLAV · AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION · +28 more5928Yes
Piperacillin And Beta-Lactamase InhibitorJAMP-PIP/TAZ · PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION · PIPERACILLIN AND TAZOBACTAM FOR INJECTION · PIPERACILLIN/TAZOBACTAM FOR INJECTION · +5 more5216Yes
Ticarcillin And Beta-Lactamase InhibitorTIMENTIN20Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC J01C

ATC subgroupMoleculesDINsMarketed
J01CAAmoxicillin · Ampicillin · Ampicillin, Combinations · Bacampicillin · Piperacillin · +3 more20147
J01CFBeta-Lactamase Resistant Penicillins · Cloxacillin · Flucloxacillin429
J01CEBenzathine Benzylpenicillin · Benzathine Phenoxymethylpenicillin · Benzylpenicillin · Combinations · Phenoxymethylpenicillin · +1 more694

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is SANDOZ AMOXI-CLAV TABLET called?

The same molecule, Amoxicillin And Beta-Lactamase Inhibitor, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
AUGMENTINLatinBahrain, Czechia
AmoxilLatinAustralia, Bahrain
APO-AmoxycillinLatinAustralia
Amoxycillin SandozLatinAustralia
OmacillinLatinBahrain, Saudi Arabia
Amimox®LatinSweden
BetaklavLatinCzechia, Sweden
KLAVOXLatinBahrain
AMILOXYNLatinAustralia
APX-Amoxicillin/Clavulanic AcidLatinAustralia
CilamoxLatinAustralia
COMOXLatinAustralia
CuramLatinAustralia, Bahrain
AMOXICILLIN-WGRLatinAustralia
MOXICLAVLatinBahrain

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for SANDOZ AMOXI-CLAV TABLET

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02482584. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.